Cat. No : F-NCOV-01G. STANDARD F COVID-19 Ag FIA is the fl uorescent immunoassay for the qualitative detection of specific nucleoprotein antigens to SARS-CoV-2 present in human nasopharynx. STANDARD F COVID-19 Ag FIA should be used with the STANDARD F Analyzers manufactured by SD BIOSENSOR. This test is for in vitro professional diagnostic use and intended as an aid to early diagnosis of SARS-CoV-2 infection in patient with clinical symptoms with SARS-CoV-2 infection.
Cat. No : 5513C. COVID-19 serology test.Cellex qSARS-CoV-2 IgG/IgM Rapid Test.qSARS-CoV-2 IgG/IgM Rapid Test Cassette.FDA Grants Emergency Authorization for First Rapid Antibody Test for COVID-19
DYMIND COVID-19 Antigen Test Kit (Saliva Test Kit) - For Self Testing SARS-CoV-2 Antigen Test Kit (colloidal gold method) MALAYSIA DRUG AUTHORITY (MDA), KKM APPROVED Accurate + Fast + Easy Sensitivity: (95% CI): 123/129 95.35% (90.15% -98.27%) Specificity: (95% CI): 160/16398.16% (93.84% -99.33%) Ct count
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
1. Generic Name: Novel Coronavirus COVID-19 IgG Antigen Test Kit 2. Brand Name: NIL 3. Notified Category: Other than above substances intended for qualitative determination of COVID-19 infection 4. Class of Medical Device: Class D 5. Shelf life :15 months 6. Sterile/Non-Sterile: Non-Sterilized 7. Contains Drugs: No 8. Medical Device Grouping Category: IVD-Kit 9. Grouping Description: Intended for qualitative determination of COVID-19 infection 10. Intended Use: The Novel Coronavirus COVID-19 IgG Kit is intended for the qualitative detection of human anti-COVID- 19 IgG antibody in human serum/plasma. Any reactive specimen with the Novel Coronavirus COVID-19 IgG Kit must be confirmed with alternative testing method(s). 11. Product Description: Assay controls and 1:10 diluted human serum samples are added to the microtiter wells of a microplate that was coated with COVID-19 recombinant full length recombinant protein. After the first incubation period, the unbound protein matrix is removed with a subsequent washing step. A horseradish peroxidase (HRP) labeled polyclonal goat anti-human IgG tracer antibody is added to each well. After an incubation period, an immunocomplex of "COVID-19 recombinant antigen-human anti-COVID-19 IgG antibody - HRP labeled anti human IgG tracer antibody" is formed if there is specific Coronavirus IgG antibody present in the tested specimen. The unbound tracer antibody is removed by the subsequent washing step. HRP-Labeled tracer antibody bound to the well is then incubated with a substrate solution in a timed reaction and then measured in a spectrophotometric microplate reader. The enzymatic activity of the tracer antibody bound to the anti-COVID-19 IgG on the wall of the microtiter well is proportional to the amount of the anti-COVID-19 IgG antibody level in the tested specimen. SALIENT FEATURES: â?¢ Recombinant COVID-19 Spike subunit Protein coated on Microwell Plate â?¢ HRP Conjugated Polyvalent Anti-Human IgG â?¢ Assay Time: 80 mins (30mins+30 Mins+20mins) â?¢ Strip Format Microwell Plate â?¢ Ready to use Substrate and Controls â?¢ Only 20 pL of human serum is required for measurement in duplicate. â?¢ Works on any open ELISA system â?¢ Assay procedure is easy to automate OUR TEST: â?¢ Principle: Indirect ELISA â?¢ The normal healthy patients with samples collected prior to the COVID-19 outbreak [December 3, 2019] (n = 150) and RT-PCR confirmed positive patients in after the second week of the onset of the disease (n = 32). The Positive sample evaluation was done at external Approved Lab. The results are as follows: â?¢ Diagnostic sensitivity is 100% (>98%) â?¢ Diagnostic specificity is 98.67% (>97%) â?¢ PPV: 94.12�°/0 â?¢ NPV: 100% Please contact us for more information and product details.
COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of
We can supply millions of Rapid Test Kit for Covid 19 using Saliva or Swab immediately. Interested serious clients may contact us directly on our given email or WhatsApp. Dr.Prdeep Raman Foodex International
Test results in 10 minutes. Suitable for fingertip blood, serum, plasma and whole blood. Test both IgM and IgG antibodies. CE certified Production capacity: 500,000/ day Price: 5.9 USD (negotiable for big quantities)
Nuactor viral RNA extraction kit
COVID-19 antibody test 1 PU * (25 pieces) from 4 PUs : one FFP2 mask per test free of charge * PU = packaging unit; 1 PU = 25 pieces; Offer valid while supplies last. PU = Packing unit; 1 PU = 25 pieces; Offer valid while supplies last. For bulk orders of 1000 or more, please contact us
We supply: COVID-19 tests Tests: COVID-19 IgM COVID-19 IgG COVID-19 Antigen Rapid Test COVID-19 A+B.
Covid 19 detection kit, famous for efficient detection of Covid 19/coronaVirus made in south korea
Corona Antigen Rapid Test Kits USD 4.85 FOB.
A box 2 doses I HEALTH price $6+10% A Box 1 dose Flow Flex Price $4.4 +10% You can be seller mandate DDP USA AND ALL OVER WORLD ATTENTION PAYMENT SBLC or BCL /PB Moq 500K MAX 5-10MX12Month DDP USA or World BY AIR Buyer side 50% Commission open You can be seller part 10% of 50% for you SOP: 1, Documents NCNDA ICPO KYC 2 Seller FCO 3 DRAFT SPAï¼?DRFT SBLC OR BCL /PB 4 SPA sign &IMFPA 5 ATTENTION PAYMENT SBLC/BCL /PB / TT 6,Can get Allocation letter after confirm payment 7 DDP buyer Port Inspection pay TT 8 Then keep rolling for next deal Notice 1, You can Mark up 2 you can be seller part 3 DDP to your warehouse 2022 Feb 26-Mar 10
The n-FasT SARS-CoV-2 diagnostic kit, has the Lamp method, which is among the most reliable detection methods. The reaction that reveals the diagnosis result for Covid-19 in a fast, practical and safe way yields results with a colorimetric method based on colour change. n-FasT differs from all other kits with the opportunity to give results below the patient within 30 minutes in application and with 97 % success rate result interpretation.
25 tests per box, CE certificate
ALL OTG PO from Buyer CI from Seller Buyer signs and returns the CI Seller's Attorney prepared LOA and submits to Buyer Escrow Agreement from Seller is signed Buyer escrows funds for full purchase SGS inspection is performed at buyer's expense Logistics details are exchanged Upon confirmed report, escrowed funds are released simultaneous with title transfer
Product Description The iHealth COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. Pricing: $5.5 PER KIT OF 2 TESTS MOQ: 1 pallet: 84 cartons / 7560 boxes / 15,120 tests Maximum Quantity: Please inquire Shipping Information: 90 Packs per Carton, 2 Tests per Pack 1 pallet: 84 cartons / 7560 boxes 1100 lbs Per pallet Single Package Dimensions (LxWxH) 6.18 x 3.19 x 0.71 Inches Single Package Weight (lb) 0.13 Carton Dimensions (LxWxH) 13.1 x 11.8 x 10.8 Inches Carton Weight (lb) 12.8